1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Pyelitis: new trials by email Literature Review of Pyelitis trials Research Report on Pyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis NRX101 (a fixed dose combination of D-cycloserine (DCS) and lurasidone HCl (lurasidone)) - Urinary Tract Infections, Pyelonephritis | Phase 2 | Unknown | NeuroRx, Inc. | 13 | 2024-03-31 | 2023-11-13 |
Pyelonephritis (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infections (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nephritis (1) · Nephritis, Interstitial (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Cycloserine (1) · Lurasidone Hydrochloride (1)
NeuroRx, Inc. (1)